Sign inJoin waitlistJoin the waitlist

MB

Minal Barve

Physician · Texas Oncology

Credentials: · · · ·

History

Texas Oncology
Present

Baylor University Medical Center
2001–2003
Baylor University Medical Center
2002–2003
Internal Medicine
Texas Health Resources/ Presbyterian Hospital Dallas
1994–1997
Obstetrics and Gynecology
Baylor University Medical Center
1993–1997
Dr. Panjabrao Deshmukh Memorial Medical College
1989–1993

Research

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
The Lancet Oncology · 2020 · 1,363 citations
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
New England Journal of Medicine · 2023 · 448 citations
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
The Lancet · 2021 · 391 citations

JN
John Nemunaitis
16 papers
NS
Neil Senzer
12 papers
AS
Alexander Spira
7 papers
Manish Patel
6 papers
David Hong
5 papers
MJ
Melissa Johnson
5 papers
MP
Meredith Pelster
5 papers
Afshin Dowlati
4 papers
AS
Alexander Starodub
4 papers
Bita Fakhri
4 papers
DT
Donald Tsai
4 papers
Ignacio Garrido-Laguna
4 papers

Clinical trials

HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors
Principal investigator · Recruiting · Phase 1
HighField Biopharmaceuticals Corporation
2023–2027
Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer
Principal investigator · Terminated · Phase 1
Intezyne Technologies, Inc.
2017–2019
Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers
Principal investigator · Completed · Phase 2
Mary Crowley Medical Research Center
2016–2020
Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer
Principal investigator · Active not recruiting · Phase 2
SynerGene Therapeutics, Inc.
2015–2026